DigitCells

01/30/2026

Not all digital pathology monitors are created equal. A new study found that a medical-grade display achieved 100% concordance with glass for H&E slides, while professional and consumer monitors reached only 85–95% agreement. As labs expand digital and remote diagnostics, clinically validated, calibrated medical displays will be key to supporting diagnostic accuracy, reproducibility, and patient safety.

Read more:

01/28/2026

What does it really mean to modernize pathology?

In our latest blog, DigitCells COO Scott Kilcoyne reflects on two decades in the field and shares how lessons from the procedure room are shaping the next era of diagnostics. Explore the four defining shifts transforming pathology workflows, from context-aware reporting to real-time transparency. This is more than a tech evolution; it’s about putting the patient back at the center of every slide.

Read more: https://digitcells.com/tpost/ec2k4r08e1-the-patient-in-the-slide-a-new-year-refl

01/16/2026

Digital pathology and AI hold transformative power for global healthcare, but developing countries face critical barriers like inconsistent imaging standards, limited annotated datasets, and gaps in technical training. Collaborative models in India and Sub-Saharan Africa prove that international partnerships, standardized protocols, and targeted capacity building can overcome these challenges and deliver equitable diagnostic innovation.

Read more: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1657679/full

Computational pathology holds the promise of transforming the field of pathology by enabling faster and more accurate diagnosis and treatment planning. Digit...

01/07/2026

Artificial intelligence is rapidly changing laboratory medicine, but rigorous validation is essential before it becomes routine practice. Experts stress that every AI tool, even if FDA-approved, must be thoroughly verified for accuracy, bias, and workflow impact. As laboratories gain experience integrating AI into cancer detection and diagnostics, careful monitoring and human oversight remain key to ensuring reliable, effective use.

Read more:

Charna Albert December 2025—As more laboratories explore the use of artificial intelligence, the CA...

01/01/2026

Happy New Year! 🥳🎉🎊

A new year brings new possibilities, and we're energized by what's ahead in digital pathology. To our clients, collaborators, and team: thank you for making 2025 a memorable and productive year. We're looking forward to the work we'll do together, the problems we'll solve, and the progress we'll achieve.

12/23/2025

🎄 Season's greetings from DigitCells! 🎄

This year has been filled with collaboration, growth, and shared success. We're thankful for every partner, client, and team member who brought their expertise and energy to our mission. May your holidays be joyful, restful, and filled with the people who matter most.

12/12/2025

Stop thinking “faster” is the finish line. The real milestone for digital pathology is building accountability into every step of diagnosis. Today’s technologies aren’t just making workflows smoother—they’re empowering pathologists with transparency, integrity, and traceable confidence in every case. Explore how digital pathology and AI are strengthening trust and equity across the global diagnostic landscape.

Read the full blog: https://digitalpathologyassociation.org/blog/the-silent-imperative-of-accountability-beyond-efficiency-in-digital-pathology

The Silent Imperative of Accountability Beyond Efficiency in Digital Pathology   The most profound transformation digital pathology offers...

11/27/2025

We are grateful for the trust and support of our community this Thanksgiving. Wishing you a joyful holiday filled with warmth, health, and gratitude. Happy Thanksgiving from all of us!

11/07/2025

LUGPA 2025 is underway! Stop by our pop-up at GoPath Diagnostics booth #410 to discover how TWO-D streamlines tissue handling—delivering speed, simplicity, and reliability at every step.

11/06/2025

A prostate biopsy’s accuracy doesn’t just depend on the pathologist—it begins the moment tissue leaves the patient.

Pre-analytical errors like core fragmentation and data mismatches are quietly undermining diagnostic confidence and treatment decisions. Our latest insights explore how integrated tissue handling preserves specimen quality, ensures full digital traceability, and transforms pathology workflow efficiency.

This shift isn’t incremental—it’s redefining reliability in prostate cancer diagnostics.

Read more: https://digitcells.com/tpost/9lps7fhvh1-the-hidden-crisis-in-prostate-biopsy-how

10/27/2025

Still handling prostate biopsy cores the old way? There’s a better solution.

Visit us at our pop-up at GoPath Diagnostics’ booth #410 during the LUGPA Annual Meeting to see how TWO-D simplifies tissue handling from start to finish—reduces steps, saves time, and prevents fragmentation.

10/14/2025

Join us at the 2025 LUGPA Annual Meeting in Chicago!

We’ll be hosting a pop-up at GoPath Diagnostics’ booth #410 to showcase TWO-D, our streamlined solution for prostate biopsy workflow optimization. TWO-D simplifies tissue handling from collection to analysis—no need to pick cores from formalin jars or other devices. By reducing steps, saving time, and minimizing fragmentation, it helps ensure consistent, efficient results for your lab or practice.

Stop by our pop-up to see how TWO-D brings automation and precision to digital pathology.